Big pharmaceutical companies argue that knock off GLP-1 drugs are misleading consumers and violating trade laws.

A consumer safety group says the FDA has sent more than 50 warning letters to telehealth companies over claims about ...

SCHD is no longer an attractive long-term allocation, given recent reconstitution and macro dynamics favoring growth assets. Read more on SCHD ETF here.

MANILA, Philippines — The prosecutors in the impeachment trial of Vice President Sara Duterte are scrambling to expedite the ...

Ebony Bell convicted and handed community work order following assault on senator and second ‘gratuitous act of violence’ while on bail ...

Building Dreams ...

The book presents a diverse array of useful perspectives — though India is not a lone contributor or victim as painted ...

Joe Maginot discusses AI-driven U.S. stock gains, rising valuation risks and why overlooked quality growth companies may ...

Chimera Investment (CIM) holds steady amid macro headwinds and shrinking origination margins; dividend remains covered. See ...

What one writer learned from his second tournament round of the year.

A double-century by relative newcomer Amir Jangoo and 194 from captain Roston Chase put the West Indies in a commanding ...

As much of the Eastern U.S. experiences potentially record-breaking daytime temperatures, the nights are also staying ...